4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-22-002329
Chief Accounting Officer acquired 2,287 shares (grant or award)
- Chief Accounting Officer gave up 269 shares (to pay taxes)
- Chief Accounting Officer acquired 775 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Megna Michael R · Chief Accounting Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-06-30 | Grant or award : show line 1 in the form | +641 | $9.51 | $6,096 | 1,778 | D |
| 2020-12-31 | Grant or award : show line 2 in the form | +405 | $15.02 | $6,083 | 2,183 | D |
| 2021-07-15 | Grant or award : show line 3 in the form | +588 | $11.49 | $6,756 | 2,771 | D |
| 2022-01-15 | Grant or award : show line 4 in the form | +653 | $9.63 | $6,288 | 3,424 | D |
| 2022-03-16 | Exercise or conversion : show line 5 in the form | +775 | 4,199 | D | ||
| 2022-03-16 | Shares withheld for taxes : show line 6 in the form | −269 | $10.13 | $2,725 | 3,930 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-16 | Exercise or conversion : show line 7 in the form Restricted Share Unit | −775 | 2,323 | D |
Loading xslF345X03/edgar.xml…